With continued changes in science and technology, gastroenterology practice continues to evolve with a greater emphasis on an integrated healthcare delivery model that will improve patient outcomes. ACG 2022 offered GI physicians the opportunity to learn the latest clinical information on key GI topics, share practice experiences, and see the latest advances in GI diagnostics…
Sulfate-reducing bacteria (SRB) in the gut produce Hydrogen Sulfide (H2S) internally and externally in humans. H2S plays an essential role in the control of vascular homeostasis, and ongoing studies have shown that extreme levels of SRB in the gut may cause small intestinal bacterial overgrowth (SIBO). Gastrointestinal disorders such as irritable bowel syndrome, ulcerative colitis,…
Small Intestinal Bacterial Overgrowth (SIBO) is a digestive condition that is a common root cause of symptoms including constipation, diarrhea, bloating, gas, and acid reflux. While this collection of symptoms is typically attributed to Irritable Bowel Syndrome (IBS), SIBO offers a deeper understanding of why these symptoms occur. It also provides a path to resolution…
Each year, Digestive Disease Week® (DDW) brings the gastrointestinal (GI) community together to exchange knowledge, formulate ideas and uncover new ways to improve the lives of those living with digestive diseases. Gastroenterologists, researchers, and other industry professionals gathered in San Diego and virtually for DDW2022® to share best practices, ground-breaking research, and industry expertise. Following…
Digestive Disease Week® 2022 (DDW 2022) is the world’s premier meeting for gastroenterology, hepatology, endoscopy, and gastrointestinal surgery. Sponsored by four leading societies — AASLD, AGA, ASGE, and SSAT — DDW brings physicians, researchers, and other industry professionals together to exchange knowledge, formulate ideas and uncover new ways to improve the lives of those living with…
Best Practices for IBS Diagnostics & Treatment with Dr. Shanti Eswaran | Michigan Medicine Irritable Bowel Syndrome (IBS) affects an estimated 10-15% of the worldwide population with up to 45 million people living with this functional GI disorder daily. Its one of the most burdensome chronic ailments reported by GI patients, and in a survey…
The COVID-19 pandemic has brought aerosol-related diseases to the forefront of the healthcare conversation. Health systems and GI practices alike continue to grapple with the best ways to diagnose and treat patients in a specialized, affordable, and safe manner. As telehealth and virtual visits become a mainstay in the healthcare delivery model, so must the…
A recent study concludes that a single methane measurement (SMM) from a hydrogen and methane breath test can accurately diagnose intestinal methanogen overgrowth (IMO), potentially replacing the standard 2-hour breath test. A Single Fasting Exhaled Methane Level Correlates With Fecal Methanogen Load, Clinical Symptoms and Accurately Detects Intestinal Methanogen Overgrowth, which analyzes the ability of…
When patients present with symptoms related to functional gastrointestinal (GI) disorders or Disorders of the Gut-Brain Interaction (DGBI) like Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methanogen Overgrowth (IMO), and Carbohydrate Malabsorption, the recommended method of diagnosis is clinical breath testing. Each breath test – overseen by providers at healthcare facilities or taken by patients in…
The GI community continues to work in unprecedented times caused by impact of the COVID-19 pandemic. Patients have seen increased prevalence and flare-ups of GI-related symptoms due to increased stress and anxiety along with changes in dietary and exercise habits, while providers have had to navigate changes to the healthcare delivery model. As we wrap…
